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Quorum Sensing in Candida albicans:
Probing Farnesol’s Mode of Action
with 40 Natural and Synthetic Farnesol Analogs
This finding was confirmed by Ramage et al. [3] who
observed unimpaired growth rates up to 300 M farne-
sol. The yeast-mycelia transition is critical for pathoge-
nicity, and C. albicans mutants limited to the yeast mor-
phology are avirulent [4]. A follow-up question based
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University of Nebraska on this discovery is to identify farnesol’s mode of action
in blocking germ-tube formation in C. albicans. One wayLincoln, Nebraska 68588
of approaching this question is to design, prepare, and
assay analogs of farnesol with the expectation that com-
parison of the activity profiles would identify essentialSummary
and extraneous structural features. There is also the
possibility of synthesizing a compound with greater ac-The dimorphic fungus Candida albicans produces
extracellular farnesol (3,7,11-trimethyl-2,6,10-dodeca- tivity than that of farnesol. Analogs with enhanced activ-
ity could prove useful in a clinical setting for preventiontriene-1-ol) which acts as a quorum-sensing molecule
(QSM) to suppress filamentation. Of four possible geo- or prophylaxis of Candidiasis. This study looks at a se-
ries of first generation analogs of farnesol and beginsmetric isomers of farnesol, only the E,E isomer
possesses QSM activity. We tested 40 natural and syn- to uncover the biology of the quorum-sensing response
in Candida albicans as mediated by farnesol. To date,thetic analogs of farnesol for their activity in an
N-acetylglucosamine-induced differentiation assay for we have analyzed 40 analogs of farnesol. Of these, 22
show activity as determined by their ability to reducegerm tube formation (GTF). Modified structural fea-
tures include the head group, chain length, presence germ tube formation by at least 50% at concentrations
up to 100 M.or absence of the three double bonds, substitution of
a backbone carbon by S, O, N, and Se heteroatoms, As well as gaining a better understanding of the biol-
ogy of fungal quorum sensing, there are at least fourpresence or absence of a 3-methyl branch, and the
bulkiness of the hydrophobic tail. Of the 40 com- practical advantages to be gained from farnesol ana-
logs. (1) Preliminary experiments with a mouse modelpounds, 22 showed QSM activity by their ability to
reduce GTF by 50%. However, even the most active show no obvious toxicity from farnesol. However, if far-
nesol toxicity were to become a problem at higher dos-of the analogs tested had only 7.3% of the activity
of E,E-farnesol. Structure-activity relationships were ages or with prolonged treatment, it would be desirable
to develop less toxic analogs that still maintain QSMexamined in terms of the likely presence in C. albicans
of a farnesol binding receptor protein. activity. (2) Farnesol has limited water solubility. Modifi-
cations of the structure of farnesol might lead to active
compounds that were more soluble and thus more easilyIntroduction
deliverable in animal systems. (3) Analogs of farnesol
might also possess improved pharmacokinetics, suchThe dimorphic fungus Candida albicans is the first
eukaryotic system shown to possess quorum-sensing as an enhanced ability to enter the blood stream via the
gastrointestinal tract or peritoneum. Alternatively, sincebehavior [1]. Quorum sensing has been thoroughly de-
scribed in prokaryotes but had not been demonstrated farnesol is usually excreted from animals after its con-
version to farnesoic acid and dicarboxylic acids [5], spe-in eukaryotes until recently. With this phenomenon, a
secreted compound accumulates to a critical concen- cific structural changes may improve retention. Both
scenarios could help maintain the analog in an availabletration in the medium and then acts back on the produc-
ing cells to elicit a physiological response. For Gram- form in the host. (4) While our in vitro studies suggest
a possible prophylactic use for farnesol, it is still unclearnegative bacteria, the quorum-sensing molecules are
all members of a family of compounds known as acyl whether this will be seen in an animal model. Farnesol
could prove to act as a virulence factor for C. albicans.homoserine lactones [2]. In the case of C. albicans, the
quorum-sensing molecule (QSM) is the sesquiterpene This question was posed by Hornby et al. [1] based
upon anticipated differences between in vitro studiesfarnesol (3,7,11-trimethyl-2,6,10-dodecatriene-1-ol). Ac-
cumulation of farnesol blocks the morphological shift performed in a glass vessel and in vivo studies, where
cellular membranes might act as a sink for the lipophilicfrom yeasts to mycelia [1]. Farnesol blocks germ tube
formation as triggered by serum, proline, or N-acetylglu- farnesol. If farnesol functions as a virulence factor for
C. albicans, it would be important to develop farnesolcosamine, and it is produced by and active on all (five)
strains of C. albicans tested [1]. analogs that act as antagonists of virulence.
The effect of farnesol concerned morphological
choice, not growth rate. At concentrations of up to 250
ResultsM, farnesol did not alter the growth rate for C. albicans;
actively budding yeasts were observed in all cases [1].
Our previous work [1] reported that both commercial
mixed isomers farnesol and 96% E,E-farnesol exhibited*Correspondence: knickerson1@unl.edu
3These authors contributed equally to this work. QSM activity. However, subsequent comparisons with
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Table 1. QSM Activity of Three Commercial Samples of Farnesol
Calculated Concentration
Concentration Concentration (M) for 50% GTF Based
Farnesol Source Percent E,E-Farnesola (M) for 0% GTFb (M) for 50% GTFb on Percent E,E-Farnesolc
Sigma E,E-farnesol 96 7.5 1.2 1.2
Sigma mixed isomers 56 25 3.5 2.1
Across mixed isomers 36 30 4.4 3.2
a Determined by GC/MS as previously described [1].
b Based on the regression analysis as described in Experimental Procedures.
c Calculated values of concentration that would be needed if all observed activity were due to E,E-farnesol only, based on the known E,E-farnesol
content of each sample.
freshly opened bottles of farnesol showed significantly activity. An analog was considered to be active if it
was capable of reducing GTF by 50% at concentrationsgreater activity with the E,E isomer (Table 1) and differing
activities with mixed isomers farnesol from different of 100 M. In practice, this definition meant that ana-
logs were considered active if they had 1% of thesuppliers (Table 1). Ninety-six percent E,E-farnesol re-
duced GTF to fifty percent at 1.2 M, with complete activity of E,E-farnesol. Farnesoic acid (analog 2, 3.3%
relative activity) and the corresponding amide (3, 1.9%)inhibition at ca. 7.5 M (Table 1) while mixed isomers
farnesol from Sigma (St Louis, MO) and Acros Organics maintained biological activity, whereas the aldehyde (4,
0.4%), bromide (5, 0.7%), methyl ester (6, 0.1%), and(Pittsburgh, PA) reduced germ tube formation (GTF) to
50% at ca. 3.5 and 4.4 M, respectively (Table 1). The amine (7, 0.1%) were inactive (Table 2). The sulfhydryl
analog was too insoluble to be bioassayed. In particular,three farnesol samples were therefore analyzed by GC/
MS. The lower activity Acros mixed isomers farnesol farnesoic acid, which has also been identified as a QSM
produced by C. albicans [6], displayed only 3.3% of thecontained only 33%–36% E,E-farnesol, whereas the
higher activity Sigma mixed isomers farnesol contained activity exhibited by farnesol (Table 2). With regard to
farnesol’s mode of action, it is significant that the hy-56% E,E-farnesol (Table 1). There was sufficient E,E-
farnesol in the two mixed isomers samples to account droxyl head group is not essential for QSM activity (Table
2). This conclusion is supported by the observation offor their QSM activities (Table 1). Based upon the per-
centage of E,E-farnesol in the Sigma and Acros Organics Matsuoka and Oh that -farnesene, with no functional
groups whatsoever, retained QSM activity [7].samples, reduction to 50% GTF would have been ex-
pected to occur at concentrations of 2.1 and 3.2 M,
respectively (Table 1). These concentrations are lower Double Bond Modifications
than those determined experimentally for the mixed iso- We next examined five analogs based upon alterations
mers samples. Thus, it appears that only E,E-farnesol of the 2,3 double bond in farnesol (Table 3). The 2,3
possesses QSM activity, and furthermore, a comparison cyclopropane ring analog (8, 3.3%) maintained biologi-
of observed QSM activity (Table 1) with that predicted cal activity, whereas the 2,3 epoxide (9, 0.4%) and 2,3
by the E,E-farnesol content suggests the other isomers hydrogenated (10, 0.4%) analogs were inactive (Table
may even act to inhibit QSM activity. 3). The terminal 10,11 double bond was also essential
for activity in that the 10,11 hydrogenated (11, 0.3%)
and fully hydrogenated (12, 0.3%) analogs were inactiveHead Group Modifications
(Table 3). Not unexpectedly, all-trans retinol (vitamin A),We tested six farnesol analogs with altered head groups
a farnesol analog with five conjugated double bonds(Table 2). These modifications were introduced to learn
and a bulky, cyclic tail group was also inactive (data notwhether farnesol’s C-1 hydroxyl was essential for QSM
shown).
Sulfur-Containing AnalogsTable 2. Biological Activity of Famesol Analogs Based on
We next tested a series of 14 analogs that incorporatedModified Head Groups
sulfur atoms in place of a main chain CH2 unit (Tables
4 and 5). Seven of the eight analogs with a sulfur in the
4 position retained QSM activity (Table 4) including both
the E- and Z- isomers of 4-thia farnesol (13, 3.7% andAnalog Relative
Number X  IC50 (M)a Activity 14, 3.4%, respectively). Surprisingly, the 2,3 hydroge-
nated 4-thia analog (15, 7.3%) retained activity (Table1 CH2OH (Farnesol) 1.2 100.0
4), to the extent that it was ca. 16-fold more active than2 COOH (Famesoic Acid) 36.2 3.26
3 CONH2 62.3 1.89 the 2,3 hydrogenated analog (10) of farnesol itself (Table
4 CHO (Farnesal) 0.38 3). The importance of the proximal 3-methyl side chain
5 CH2Br (Commercial E,E) 0.75 in the 4-thia series was examined (Table 4) via compari-
6 COOCH3 0.10 son of the methylated compound 15 with the demethyl-7 CH2NH2 0.14
ated series represented by compounds 16 (3.7%), 17
a Inhibitory concentration (M) at which germ tube formation is re- (1.5%), and 18 (1.7%). All three demethyl analogs re-
duced to 50%.
tained activity, as did the 3,4 disulfide (19, 1.6%). We
40 Farnesol Analogs and Candida albicans
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Table 3. Biological Activity of Farnesol Analogs Based on Modifications to Their 2,3 Double Bond
Analog
Number Double Bond Modification IC50 (M) Relative Activity
1 None 1.2 100.0
8 2,3-cyclopropane 35.9 3.26
9 2,3-epoxide 0.38
10 2,3-hydrogenated 0.45
11 10,11-hydrogenated 0.31
12 Hydrogenate all three double bonds 0.31
X 
27 68.7 1.72
28 23.2 5.08
29 24.4 4.80
can then make the comparison among three compounds The 9-thia series with n-butyl (21, 4.9%), isobutyl (22,
2.6%), and t-butyl (23, 0.9%) showed decreasing activity(17, 15, and 20 [0.5%]) with increasingly bulky 3-side
chains (Table 4); activity increases 5-fold with insertion with increased branching (Table 5). The relative inactivity
of the t-butyl 9-thia analog (23) should not be due merelyof the 3-methyl (15 versus 17) and then decreases 16-
fold with the bulkier 3-ethyl (20 versus 15). to greater hydrophobicity because the n-pentyl (24,
1.8%), benzyl (25, 1.7%), and phenyl (26, 1.5%) 9-thiaSimilarly, five of the six analogs with the sulfur atom
in the 9 position also retained QSM activity (Table 5). analogs still had QSM activity (Table 5). However, it
Table 4. Biological Activity of Farnesol Analogs with Sulfur Atoms at the 4 Position
Analog Relative
Number X  IC50 (M) Activity
13 (trans) 32.1 3.67
14 (cis) 35.1 3.36
15 16.0 7.34
16 31.6 3.70
17 79.1 1.47
18 67.0 1.75
19 (disulfide) 72.4 1.61
20 0.48
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could reflect the bulkier cross-section of the t-butyl be- Table 5. Biological Activity of Farnesol Analogs with Sulfur
Atoms at the 9 Positioning unable to fit into the narrow cleft of a farnesol re-
ceptor.
Chain Length Modifications Analog Relative
Farnesol is a 15 carbon sesquiterpene; it has a 12 carbon Number X  IC50 (M) Activity
chain with three methyl branches. We next examined
21 n-butyl 23.8 4.94whether altering the chain length alters QSM activity.
22 Isobutyl 44.3 2.64
Three demethylated, 2,3-hydrogenated analogs (27, 23 tert-butyl 0.86
1.7%; 28, 5.1%; and 29, 4.8%) have chain lengths of 24 n-pentyl 66.8 1.75
25 Benzyl 68.9 1.7210–12 carbons (Table 3) and lack the 2,3 double bond
26 Phenyl 79.2 1.47and 3-methyl branch found in farnesol. Compounds
27–29 all exhibited activity, suggesting some flexibility
with regard to chain lengths. This flexibility with regard
to chain length was also shown by the 4-thia (Table 4) regard to the head group (Table 2), double bonds (Table
and 9-thia (Table 5) analogs. Counting S and -CH2- as 3), chain length (Tables 3 and 4), and the presence of
equivalent, compounds 16–18 in the 4-thia series (with sulfur and selenium heteroatoms in the farnesyl back-
chain lengths of 11–13, respectively) all had QSM activity bone (Tables 4–6). All of our assays involve adding ana-
(Table 4) as did compounds 21 and 24 in the 9-thia series logs to cells programmed for GlcNAc-induced germ
(with chain lengths of 13–14, Table 5). tube formation. Thus, if we assume that there is an
intracellular target/receptor for farnesol, the exogenous
Heteroatoms in the Carbon Chain farnesol must cross the cytoplasmic membrane and
Based on our success with the sulfur-containing analogs then bind to the target. Therefore, the administered level
(Tables 4 and 5), we tried a series of other heteroatoms of farnesol or farnesol analog may not reflect the actual
at the 4 and 9 positions (Table 6). The 4-Se analog (30, intracellular concentration available to the receptor or
2.6%) was the only one which retained QSM activity; target. As a corollary, a farnesol analog could be inactive
all the O-containing analogs and the one N-containing either because it has difficulty crossing the membrane
analog (31, 0.03%) were inactive (Table 6). In each case, or difficulty binding to the target. For instance, it is rea-
the oxygen-containing analog was less active than the sonable to suppose that the dihydroxy analog (40) and
corresponding sulfur-containing analog. Compound 32 the analogs containing a basic nitrogen (7 and 31) might
(0.1%) was 21-fold less active than 17, compound 33 have difficulty crossing the cytoplasmic membrane. Our
(0.5%) was 14-fold less active than 15, compound 34
(0.4%) was 4.6-fold less active than 18, and compound
35 (1.0%) was 2.8-fold less active than 22. Table 6. Biological Activity of Farnesol Analogs Containing
Heteroatoms at the 4 or 9 Positions
Hydroxyl and Epoxide Analogs of Farnesol
As seen in Table 3, the epoxide at the 2,3 position (9)
was ca. 260-fold less active than E,E-farnesol. However,
Analog Relative
the epoxide at the 10,11 position (36, 1.7%) was still active, Number X  IC50 (M) Activity
as were the 10-hydroxyl (37, 1.7%) and 6-hydroxyl (38,
29 CH2 24.4 4.801.5%) analogs (Table 7). The 10,11 epoxide of farnesol is,
17 S 79.1 1.47of course, the reduced form of insect juvenile hormone III
30 Se 45.7 2.57a
(39) which has a methyl ester at the C-1 position instead 32 O 0.07
of the hydroxyl in farnesol. Thus, the QSM inactivity of 33 O (with methyl branch 0.51
added back at 3-position)juvenile hormone III (39) is expected from the inactivity
18 SCH2b 67.0 1.75of the corresponding methyl ester of farnesol (6, Table
34 OCH2b 0.382). Finally, in terms of designing a potential affinity col-
31 NCH2b 0.03umn for farnesol binding proteins, the omega-hydroxy
9-thia compound (40, 0.1%) was 49-fold less active than
its nonhydroxylated parent compound (21, Table 5).
Similarly, all other farnesol analogs with a terminal/-
hydroxyl group were inactive (data not shown). Future X 
studies will be directed toward the design of an affinity
column for farnesol binding proteins. 35 0.96
c
Discussion a Compound 30 was 33% E and 67% Z at the 6,7-double bond. If
only the E isomer was active, it would have a relative activity of
We have examined 40 natural and synthetic analogs of 7.72.
b 18, 31, and 34 have four carbons instead of three, between thefarnesol with regard to their ability to block germ tube
head group hydroxyl and the heteroatom.formation in Candida albicans. Twenty-two of the forty
c Compounds 35 and 22 are identical except that 35 has 9-O whileanalogs exhibited QSM activity. Thus, farnesol itself is
22 has 9-S.
not a requisite for QSM activity; there is flexibility with
40 Farnesol Analogs and Candida albicans
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Table 7. Biological Activity of Hydroxy and Epoxide Analogs of Farnesol
Analog
Number IC50 (M) Relative Activity
1 1.2 100
9 2,3-epoxide 0.38
36 10,11-epoxidea 68.8 1.72
37 10-hydroxylb 68.5 1.72
38 6-hydroxylb 79.2 1.47
39 Juvenile Hormone III 0.16
40 0.10
a Compound 36 is a modified (reduced) form of juvenile hormone III in which the carboxyl group has been reduced to a primary alcohol.
b Hydroxyls were introduced as racemic mixtures at the 10 (37) and 6 position (38) by hydroboration of the 10–11 and 6–7 double bonds,
respectively.
focus on a putative farnesol binding protein is made a 1,3-allylic transposition of the hydroxyl and alkene
groups, and it is possible that allylic isomerization towith full realization that existing data do not yet prove
the existence of farnesol binding proteins in C. albicans. farnesol may be the source of the “activity” of nerolidol.
The rest of the head group region, however, provedAt present, virtually nothing is known about farnesol’s
mode of action in regulating fungal cell morphology. One fertile ground for analog development. A primary alcohol
was retained as a fixed element in all designs. It is inter-of the purposes in examining this collection of farnesol
analogs was to put constraints on the possible modes esting to analyze the alkanol analogs based on the as-
sumption that the role of the farnesol C1-C4 region is toof action for farnesol. As a starting point, farnesol could
bind to a specific receptor. This receptor could be either hold the alcohol in a particular register relative to the
remainder of the molecule. The three-carbon span in 27a fungal analog of the nuclear FXR receptor found in
most higher eukaryotes [8, 9] or a different farnesol- may be too short to allow the alcohol to occupy the
same space as in farnesol, whereas the four-carbonspecific receptor. However, a genomic search of S. cere-
visiae and C. albicans failed to identify sequences similar span in 28 can achieve a farnesol-like disposition
through a low-energy extended conformation and theto mammalian FXR receptors. Thus, if activity is medi-
ated through a farnesol receptor, it is likely to be of a longer five-carbon span in 29 can adopt a similar overall
shape through introduction of a single gauche kink. Astype not previously observed.
What can we infer about the farnesol binding pocket a corollary, the inactivity of 10 suggests that the pres-
ence of a C-3 methyl on the same five-carbon spanof the putative receptor? How are conformational space
and topographical space related to molecular recogni- prevents the assumption of a farnesol-like conforma-
tion. The subtlety of these interactions is further illus-tion? One approach to our structure-activity results is
the linear approach based upon the three regions of trated by comparing removal of the 3-methyl group for
the all-carbon molecules (10 versus 29, 11-fold increasefarnesol which are altered: (i) The C1 terminal hydroxyl
group, (ii) the C1-C4 “head group” region, and (iii) the in activity), the sulfur-containing analogs (15 versus 17,
5-fold decrease in activity), and oxygen-containing ana-C9-C12 “tail” region. We have not yet analyzed enough
analogs of the C5-C8 “midchain” region to draw any use- logs (33 versus 32, 7-fold decrease in activity).
The need for a tail region was clear from the completeful conclusions. In this regard, with the exception of 30,
the central double bond of all the analogs (equivalent lack of activity of the shorter (C10) geraniol [1]. Similarly,
the lack of activity [1] of the diterpene (C20) geranylgera-to the 6,7 double bond of farnesol) retained the E config-
uration of the starting material (usually geranyl bromide niol could represent “too much” tail in terms of poor fit
into a receptor or excess hydrophobicity. Replacementor chloride). It is tempting to suggest that the 6,7 double
bond is critical for activity because compounds 13 (E ) of the terminal 4-methyl-3-pentenyl unit of farnesol with
an isobutyl ether (35) resulted in loss of activity, whereasand 14 (Z ), differing at the 2,3 double bond, had equiva-
lent activities (Table 4). the 10,11-epoxide (36) and the 10-hydroxyl (37) analogs
retained activity. Similarly, the n-butyl and isobutyl thio-The terminal hydroxyl group proved almost invariant.
Although farnesoic acid and the amide (2 and 3) dis- ethers (21 and 22) retained activity while the inactivity
of a tert-butyl thioether (23) suggested intolerance forplayed activity, functional groups of similar size (alde-
hyde, methyl ester) or hydrogen-bonding ability (amine) steric bulk in the C9-C10 region.
A second approach to our structure-activity results ispossessed no QSM activity. In this regard, the reduced
activity observed [1] for nerolidol (3,7,11-trimethyl- based on the implications of substituting heteroatoms
into the farnesol backbone. Most of the analogs con-1,6,10-dodecatriene-3-ol) could reflect either the altered
regiochemistry or increased steric bulk of the head taining a thioether retained QSM activity (Tables 4 and
5). The exact chain length did not appear to be a criticalgroup relative to the C1 primary hydroxyl of farnesol. On
the other hand, nerolidol differs from farnesol only in variable. Compare the activities of 27–29 (Table 3) and
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16–18 (Table 4). In the latter series, 16, 17, and 18 had out from our results. The epoxy (9) and cyclopropane
(8) analogs preserve much of the conformational con-two-, three-, and four-carbon spacers between the
sulfur and the hydroxyl, respectively. We note three straints of the 2,3-alkene but significantly enlarge the
cross-sectional area of the alkene. The 2,3 cyclopropanepoints of interest in activity comparisons among four
pairs of molecules, 28 and 16, 29 and 17, 10 and 15, analog maintains activity, but the more polar 2,3 epoxide
has lost activity (Table 3). The second idea in whichand 1 and 13/14, which are identical except for the
replacement of CH2 by sulfur. First, for four compounds each of three trisubstituted alkenes exerts significant
conformational constraints on the surrounding region(13/14, 16, and 17) introduction of the sulfur atom de-
creases QSM activity relative to the carbon-containing suggests an obvious role in providing bias toward partic-
ular conformers. This hypothesis is supported by ouranalog, whereas 15 displays 16-fold greater activity than
the nonsulfur analog. Second, the mixed disulfide (19) discovery that the QSM activity of commercial farnesols
correlates closely with the fraction of the natural E,E-also retains activity (Table 4). Thus, we have a sequence
of three active compounds (29, 17, and 19) with nearly isomer (Table 1). The third idea in which the alkene
units provide needed electron density fits with the strongequivalent chain lengths but containing zero, one, and
two sulfurs, respectively. The final point of note is that activity of the thioethers. Replacement of either the head
(Table 4) or tail (Table 5) alkene with a straight chaincompound 15 was one of only nine analogs tested (8–10,
20, and 36–39 were the others) that possessed a chiral thioether maintains QSM activity. However, the activity
of analogs containing linear methylene head groups (27–center. Compound 15 was prepared and assayed as a
racemic mixture; it is likely that one of the two enantio- 29) suggests that electron density in the form of an
alkene or a thioether is not essential. Thus, in summary,mers would possess even greater activity.
Thus, both the all-carbon alkanols (27–29) and the the factors which seem necessary for farnesol’s QSM
activity and binding to a presumptive farnesol bindingthiaalkanols (16–18) retain significant activity. In theory,
the corresponding O-ethers should combine the best protein include: (i) a C-1 hydroxyl; (ii) a C-3 methyl group
(but no larger); (iii) a hydrophobic tail; and (iv) the appro-features of the alkanols (similar C-O and C-C bond
lengths) and the thiaalkanols (similar conformational priate conformational constraints on backbone con-
formers as provided by the three, trisubstituted alkenespreferences). However, none of the O-ethers had activity
(Table 6). This outcome may be due to the greater polar- of farnesol. Factors which do not seem as critical in-
clude: (i) absolute chain length; (ii) the chemical structureity of the ethers as well as to an intramolecular H bond
between the O-ether and the C-1 alcohol. This explana- of the C9-C12 hydrophobic tail; and (iii) the origin of the
needed conformational constraints in the backbone. Stion is supported by a comparison between the inactive
O-ether (32) and the highly active Se-ether (30). The and Se heteroatoms are permitted.
results could also reflect the relative C-X bond lengths:
C-Se  C-S  C-C  C-O.
SignificanceA third approach to our structure-activity results is
based on the role of alkenes in providing conformational
Farnesol is a quorum-sensing molecule in Candidaconstraints on the farnesol backbone. The three trisub-
albicans that acts to block the transition from yeastsstituted alkene subunits of farnesol each impart signifi-
to mycelia. It is widely agreed that this morphologicalcant conformational constraints on neighboring link-
transition is a critical feature of this organism’s patho-ages. In particular, allylic strain from the methyl groups
genicity. A further understanding of the action of farne-at C3, C7, and C11 precludes conformations which place
sol on a molecular level could lead to better controlthe C1-O, C4-C5, or C8-C9 bonds into juxtaposition with
of this common human pathogen. To address thisthe methyl branches. Similarly, 1,2-strain disfavors con-
topic, we created a series of farnesol analogs andformations which juxtapose the C4-C5 or C8-C9 bonds
examined their ability to inhibit mycelial development.with the C3 or C7 methyl branches, respectively. The
Taken together, our results provide four major ad-importance of these alkene-induced conformational
vancements to the understanding of the molecular ac-constraints may be reflected in the lack of activity of
tion of farnesol. (1) Of the four possible geometricthe 2,3-dihydrofarnesol (10) and the 2,3,6,7,10,11-hexa-
isomers of farnesol, only the E,E isomer possesseshydro (saturated) farnesol (12). At the same time, the
QSM activity. (2) Structural analogs of farnesol thatresults from the head and tail analogs demonstrate that
retain biological activity can be synthesized. In otherneither the C2-C3 nor C10-C11 double bonds are required
words, farnesol itself is not essential for the activityfor activity; structurally related thioethers retain activity
seen in C. albicans. (3) Subtle changes in the structure(Tables 4 and 5). Given the juxtaposition of the activity
of farnesol lead to significant changes in the activity.retained by the thioethers versus that lost by removal
(4) These analogs indicate which parts of the moleculeof the double bonds in compounds 10 and 12, one can
can be altered and still retain activity and which areimagine three possible roles for the alkene units of farne-
essential for activity. This information may help in thesol: (i) fitting into a narrow cleft, (ii) precluding particular
development of second generation farnesol analogsconformations and thereby organizing the main chain
with useful pharmacokinetic properties. For instance,into the proper conformation for binding, or (iii) providing
studies using cyclization to achieve conformationalelectron density or van der Waals surface for a particular
constraint seem indicated. However, even the mostinteraction with the receptor.
active of the analogs tested had only 7.3% of the activ-Each of the ideas has attractive features, and of
ity of E,E-farnesol, and thus they are unlikely to havecourse, they are not mutually exclusive. The first idea
of a narrow cleft cannot be endorsed or completely ruled any therapeutic potential as farnesol agonists in hosts
40 Farnesol Analogs and Candida albicans
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pounds which exhibit farnesol-like activity cause a shift from germinfected by C. albicans. However, if farnesol does prove
tubes to actively budding yeasts. Previous studies indicated thatto be a virulence factor for C. albicans, these analogs
any lethal compounds or lethal concentrations instead gave phasemay prove to be effective antagonists for farnesol.
dark, undifferentiated cells. None of analogs tested exhibited toxic-
ity at concentrations up to 100 M.
Experimental Procedures
Activity CalculationsStrain and Chemicals
Two measures of analog activity were employed. In the first, weCandida albicans A72 was obtained from Patrick Sullivan, University
compared the concentrations of farnesol and the analog necessaryof Otago, Dunedin, New Zealand. A stock culture was grown in
to lower the percent germ tubes formed to 50%. An analog is consid-modified glucose-salts-biotin medium, washed in potassium phos-
ered to be active if it was capable of reducing germ tube formationphate buffer, and stored in the same buffer as previously described
by 50% at the highest concentration tested. For inactive analogs,[1]. Commercial mixed isomers farnesol (Acros Organics and Sigma),
we used an exponential decay function to model the activities ofE,E-farnesol (Sigma), and farnesal (Pfaltz and Bauer, Waterbury, CT)
the farnesol standard and the farnesol analogs according to thewere stored at 20	C with desiccant. Juvenile Hormone III, E,E-
function G  Go 
 e(b 
 C), where G represents the percentage offarnesyl bromide, and all-trans retinol (Sigma) were stored at20	C.
germ tubes, C, the concentration of sample in the assay, Go, theOur fresh farnesol samples were roughly ten times more active than
percentage of germ tubes when C  0, and b, the steepness of thethose we had reported previously [1], probably because this time
decay. At zero concentration, 95%–99% mycelia were observed forwe were scrupulous to exclude oxygen by resealing the pure farne-
all samples, and therefore, Go was fixed at 95. This allowed a singlesol oils under nitrogen and storing them with desiccation.
parameter, b, to be determined by the least-squares method using
the Maple V program (Waterloo Maple, Waterloo, CA). A commercialGeneral Synthetic and Analytical Procedures
sample of E,E-farnesol (Sigma) was chosen as the standard. TheGeneral procedures for synthesis and characterization of substrates
percentage activity for each analog was then determined by the ratiofollow. Experimental procedures and characterization data for indi-
of the calculated b values from the regression algorithm. Results arevidual compounds are found in the accompanying appendix. All
presented in the tables as “relative activity.”reagents and solvents were used as supplied commercially, except
tetrahydrofuran (THF; distilled from sodium/benzophenone), CH2Cl2
(distilled from CaH2), hexamethylphosphoric triamide (HMPA; dis- Supplemental Data
tilled from CaH2 and stored over 4 A˚ mol sieves), and N,N-dimethyl- Experimental procedures and characterization (TLC, 1H and 13C
formamide (DMF; stored over 4 A˚ sieves). Unless otherwise noted, NMR, and IR) for compounds 7, 11, 13–19, 21–23, 25, 27–35, and
reactions were run under a blanket of N2 in a round-bottom flask 37–38 can be found at http://www.chembiol.com/cgi/content/full/
equipped with a magnetic stirrer. Except where noted, NMR spectra 10/8/743/DC1; references to preparations of known compounds (3,
were taken as CDCl3 solutions at 300 MHz (1H) or 75 MHz (13C). 6, 8–10, 12, 26, and 36) are also provided.
Infrared spectra were acquired on neat films on a ZrSe crystal.
Purification of most compounds was based upon air-driven (2–5 psi)
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